Tag: Pharmaceuticals
Merck’s 2025 revenue outlook falls short as it pauses Gardasil vaccine...
Sopa Images | Lightrocket | Getty ImagesMerck on Tuesday issued full-year 2025 revenue guidance that fell short of Wall Street's expectations, as the...
Trump tariffs could raise medication costs and exacerbate shortages, drug trade...
Shana Novak | Stone | Getty ImagesPresident Donald Trump's steep tariffs on Canada, Mexico and China could worsen existing drug shortages in the...
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine...
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston.Brian Snyder | ReutersThe Food and Drug Administration on Thursday...
RFK Jr. stumbles over basics of Medicare, Medicaid during Senate confirmation...
Robert F. Kennedy Jr., U.S. President Trump’s nominee to be secretary of Health and Human Services, testifies before a Senate Health, Education, Labor,...
FDA approves Novo Nordisk’s Ozempic to treat chronic kidney disease in...
The Food and Drug Administration on Tuesday approved Novo Nordisk's Ozempic to treat chronic kidney disease in patients who also have Type 2...
Pharma is hopeful about Trump’s second term — here’s what to...
U.S. President Donald Trump speaks about prescription drug prices during an appearance in the Brady Press Briefing Room at the White House in...
UnitedHealthcare taps company veteran Tim Noel as new CEO following Brian...
UnitedHealthcare signage is displayed on an office building in Phoenix, Arizona, on July 19, 2023.Patrick T. Fallon | Afp | Getty ImagesUnitedHealthcare on...
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone...
This photo provided by Janssen Global Services shows Spravato nasal spray.Janssen Global Services via APThe Food and Drug Administration on Tuesday approved Johnson...
Ozempic is in the next round of Medicare drug price negotiations....
A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, October 31, 2023. George Frey | ReutersThe Biden administration...
Medicare’s new $2,000 cap on out-of-pocket drug costs could save patients...
Most Medicare patients who hit the new $2,000 cap on out-of-pocket spending for prescription drugs could see massive savings, despite changes in premiums,...
